Tiosano A - Search Results

1

The initial rate of tumour response to vismodegib treatment, can predict a complete response outcome for periocular LA-BCC.

Tiosano A, Ben-Ishai M, Fenig E, Ben Simon GJ, Yassur I. Tiosano A, et al. Eye (Lond). 2023 Feb;37(3):531-536. doi: 10.1038/s41433-022-01982-y. Epub 2022 Feb 24. Eye (Lond). 2023. PMID: 35210571 Free PMC article.

2

Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial.

Ben Ishai M, Tiosano A, Fenig E, Ben Simon G, Yassur I. Ben Ishai M, et al. Among authors: tiosano a. JAMA Ophthalmol. 2020 Jul 1;138(7):749-755. doi: 10.1001/jamaophthalmol.2020.1539. JAMA Ophthalmol. 2020. PMID: 32407451 Free PMC article. Clinical Trial.

3

Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial.

Gershoni A, Tiosano A, Ben Ishai M, Barayev E, J Ben Simon G, Yassur I. Gershoni A, et al. Among authors: tiosano a. Eye (Lond). 2022 Feb;36(2):407-413. doi: 10.1038/s41433-021-01493-2. Epub 2021 Mar 10. Eye (Lond). 2022. PMID: 33692538 Free PMC article. Clinical Trial.

4

Conjunctival microbiology cultures in sedated, ventilated patients in the intensive care unit.

Tiosano A, Naftali Ben Haim L, Bendavid I, Cohen JD, Avisar I. Tiosano A, et al. Eye (Lond). 2022 Sep;36(9):1835-1836. doi: 10.1038/s41433-021-01903-5. Epub 2022 Jan 26. Eye (Lond). 2022. PMID: 35082390 Free PMC article. No abstract available.

5

Academic benchmark of highly influential ophthalmologists listed in the ophthalmology power list.

Shemesh R, Tiosano A, Barayev E, Zloczower E, Gershoni A, Dotan G. Shemesh R, et al. Among authors: tiosano a. Eye (Lond). 2023 May;37(7):1503-1508. doi: 10.1038/s41433-022-02170-8. Epub 2022 Jul 18. Eye (Lond). 2023. PMID: 35851193 Free PMC article.

6

ABCD progression display for keratoconus progression: a sensitivity-specificity study.

Achiron A, Yavnieli R, Tiosano A, Elbaz U, Nahum Y, Livny E, Bahar I. Achiron A, et al. Among authors: tiosano a. Eye (Lond). 2023 Jun;37(8):1566-1570. doi: 10.1038/s41433-022-02183-3. Epub 2022 Jul 22. Eye (Lond). 2023. PMID: 35869390 Free PMC article.

7

Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration.

Tiosano A, Ben-Ishai M, Cnaany Y, Markel G, Kurman N, Popovtzer A, Bar Sela G, Ben Simon G, Gershoni A, Yassur I. Tiosano A, et al. Eye (Lond). 2023 Aug;37(12):2482-2487. doi: 10.1038/s41433-022-02358-y. Epub 2023 Jan 23. Eye (Lond). 2023. PMID: 36690728 Free PMC article.

8

Descemet Membrane Endothelial Keratoplasty Outcomes between Young and Old Graft Recipients.

Achiron A, Nahum Y, Tiosano A, Shehadeh Mashor R, Tuuminen R, Elbaz U, Bahar I, Livny E. Achiron A, et al. Among authors: tiosano a. Curr Eye Res. 2021 Oct;46(10):1460-1466. doi: 10.1080/02713683.2021.1899245. Epub 2021 Apr 11. Curr Eye Res. 2021. PMID: 33840319

9

Visual acuity outcome in patients with subretinal hemorrhage - office procedure vs. surgical treatment.

Tiosano A, Gal-Or O, Fradkin M, Elul R, Dotan A, Hadayer A, Brody J, Ehrlich R. Tiosano A, et al. Eur J Ophthalmol. 2023 Jan;33(1):506-513. doi: 10.1177/11206721221098208. Epub 2022 May 9. Eur J Ophthalmol. 2023. PMID: 35532042

10

The Effect of COVID-19 on Israeli Ophthalmology Departments: Directors' Perspectives.

Antman G, Tiosano A, Bahar I. Antman G, et al. Among authors: tiosano a. Isr Med Assoc J. 2021 Feb;23(2):76-81. Isr Med Assoc J. 2021. PMID: 33595210 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters